Biotech Values

[DewDiligence]

Buyouts of Biotech Partners

[Added Takeda-TIG.

This is a subset of the “Recent Biotech Buyouts” table that resides in the
introductory section of the Biotech Values board under the Tables heading.
This table is not intended to be exhaustive.]

Table entries are in descending order of buyout premium.

 
 Acquired                       Winning   iHub           
 Company  Buyer  Premium  Date  Bidder  Reference 
 GNLB     GSK     465%   10/08          #msg-33209281 
 MEMY     Roche   319%   11/08          #msg-33787598 
 COLY     PFE     167%   11/07          #msg-24600805 
 ICGN     PFE     150%    7/11          #msg-65365128 
 SGXP     LLY     119%    7/08          #msg-30547648 
 ENCY     PFE     118%    2/08          #msg-26978155 
 HGSI     GSK      99%    7/12          #msg-77532608 
 Speedel  NVS      94%    7/08          #msg-30588524 
 MEDX     BMY      90%    7/09          #msg-39801273 
 ZGEN     BMY      84%    9/10          #msg-54152162 
 TIG      Takeda   80%    1/18          #msg-137517859 
 FACT     BIIB‡    64%    3/10  ABT     #msg-47606240 
 MAPP     AGN      60%    1/13          #msg-83696395 
 CRXL     JNJ      58%   12/10          #msg-57504349 
 TNOX     DNA      50%   11/06          #msg-14673162 
 ICOS     LLY      25%   12/06          #msg-15623908 
 ABGX     AMGN     54%   12/05          #msg-8876857 
 IMCL     BMY‡     51%   10/08  LLY     #msg-32662830 
 SGP      MRK      34%    3/09          #msg-36140327 
 MITI     AMGN     33%    1/12          #msg-71341339

‡Spurned offer; premium and date are for winning bidder.